Drug Shortage Report for ALPROLIX

Last updated on 2022-10-12 History
Report ID 166860
Drug Identification Number 02422956
Brand name ALPROLIX
Common or Proper name ALPROLIX 3000
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN
Strength(s) 3000UNIT
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 VIAL & 5 ML PREFILLED DILUENT SYRINGE
ATC code B02BD
ATC description VITAMIN K AND OTHER HEMOSTATICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-12
Estimated end date 2022-09-26
Actual end date 2022-10-06
Shortage status Resolved
Updated date 2022-10-12
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-10-12 French Compare
v5 2022-10-12 English Compare
v4 2022-09-13 French Compare
v3 2022-09-13 English Compare
v2 2022-08-16 French Compare
v1 2022-08-16 English Compare

Showing 1 to 6 of 6